6 completed. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 3 | Completed 3 |
Follow Hypoxic-Ischemic Encephalopathy: new trials by email Literature Review of Hypoxic-Ischemic Encephalopathy trials Research Report on Hypoxic-Ischemic Encephalopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Caffeine for Hypoxic-Ischemic Encephalopathy Caffeine Citrate 5 mg/kg, Caffeine Citrate 10 mg/kg - Hypoxic-Ischemic Encephalopathy | Phase 1 | Completed | University of North Carolina, Chapel Hill | 17 | 2019-08-14 | 2025-03-27 |
| Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy Autologous umbilical cord blood cells - Neonatal Encephalopathy, Hypoxic-ischemic Encephalopathy | Phase 1 | Completed | Neonatal Encephalopathy Consortium, Japan | 6 | 2014-08-01 | 2019-10-29 |
| Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO) Erythropoietin, Normal saline - Hypoxic-ischemic Encephalopathy, Neonatal Encephalopathy | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 50 | 2013-09-01 | 2020-07-13 |
| Neonatal Erythropoietin in Asphyxiated Term Newborns erythropoietin - Hypoxic-ischemic Encephalopathy | Phase 1 | Completed | University of California, San Francisco | 24 | 2010-01-01 | 2012-11-09 |
| Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy recombinant human erythropoietin - Hypoxic-Ischemic Encephalopathy | Phase 1 / Phase 2 | Completed | Zhengzhou University | 167 | 2003-08-01 | 2008-12-16 |
| Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy hypothermia - Hypoxic-Ischemic Encephalopathy | Phase 1 / Phase 2 | Completed | Zhengzhou University | 100 | 2002-07-01 | 2009-01-06 |
Hypoxia-Ischemia, Brain (6) · Asphyxia (2) · Asphyxia Neonatorum (2) · Hypothermia (1)
Brain Diseases (6) · Brain Ischemia (6) · Cardiovascular Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Hypoxia (6) · Hypoxia, Brain (6) · Nervous System Diseases (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Signs and Symptoms, Respiratory (6) · Vascular Diseases (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Death (2) · Infant, Newborn, Diseases (2)
Epoetin Alfa (2) · Erythropoietin (2) · Saline Solution (1) · caffeine citrate (1)
University of California, San Francisco (2) · Zhengzhou University (2) · Neonatal Encephalopathy Consortium, Japan (1) · University of North Carolina, Chapel Hill (1)
United States (3) · China (2) · Japan (1)
Changlian Zhu, MD, PhD (2) · Yvonne W Wu, MD, MPH (2) · Haruo Shintaku, MD, PhD (1) · Wesley M Jackson, MD, MPH (1)
PMID 23008465, PMID 24524452, PMID 25439577, PMID 30661082, PMID 31261373, PMID 37587184